RT Journal Article SR Electronic T1 Evidence-based XAI of clinical decision support systems for differential diagnosis: Design, implementation, and evaluation JF medRxiv FD Cold Spring Harbor Laboratory Press SP 2024.07.18.24310609 DO 10.1101/2024.07.18.24310609 A1 Miyachi, Yasuhiko A1 Ishii, Osamu A1 Torigoe, Keijiro YR 2024 UL http://medrxiv.org/content/early/2024/09/13/2024.07.18.24310609.abstract AB Introduction We propose the Explainable AI (XAI) model for Clinical Decision Support Systems (CDSSs). It supports physician’s Differential Diagnosis (DDx) with Evidence-based Medicine (EBM). It identifies instances of the case data contributing to predicted diseases. Each case data is linked to the sourced medical literature. Therefore, this model can provide medical professionals with evidence of predicted diseases.Methods The source of the case data (training data) is medical literature. The prediction model (the main model) uses Neural Network (NN) + Learning To Rank (LTR). Physicians’ DDx and machines’ LTR are remarkably similar. The XAI model (the surrogate model) uses k-Nearest Neighbors Surrogate model (k-NN Surrogate model). The k-NN Surrogate model is a symphony of Example-based explanations, Local surrogate model, and k-Nearest Neighbors (k-NN). Requirements of the XAI for CDSS and features of the XAI model are remarkably adaptable. To improve the surrogate model’s performance, it performs “Selecting its data closest to the main model.” We evaluated the prediction and XAI performance of the models.Results With the effect of “Selecting,” the surrogate model’s prediction and XAI performances are higher than those of the “standalone” surrogate model.Conclusions The k-NN Surrogate model is a useful XAI model for CDSS. For CDSSs with similar aims and features, the k-NN Surrogate model is helpful and easy to implement. The k-NN Surrogate model is an Evidence-based XAI for CDSSs.Unlike current commercial Large Language Models (LLMs), Our CDSS shows evidence of predicted diseases to medical professionals.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study did not receive any funding.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors. https://www.diagnosis.or.jp/, mailto: ai.diagnosis.2021{at}gmail.com